Covid-19 Research

Clinical Trials

Tocilizumab Therapy in Giant Cell Arteritis: Insights from Clinical Experience

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Clinical Trials
Subject Medicine Group
OCLC JBRES Record
Ricardo Blanco* and Javier Loricera
Issue: Volume6-Issue8
Pages: 1163-1167
Received: 2025-08-15
Accepted: 2025-08-29
Published: 2025-08-30

Abstract

Certificate of Publication

Certificate of Publication

Copyright

© 2025 Blanco R, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Blanco R, Loricera J. Tocilizumab Therapy in Giant Cell Arteritis: Insights from Clinical Experience. J Biomed Res Environ Sci. 2025 Aug 30; 6(8): 1163-1167. doi: 10.37871/jbres2174, Article ID: JBRES2174, Available at: https://www.jelsciences. com/articles/jbres2174.pdf

Subject area(s)

References

  1. Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014 Jul 3;371(1):50-7. doi: 10.1056/NEJMcp1214825. PMID: 24988557; PMCID: PMC4277693.
  2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002 Jul 25;347(4):261-71. doi: 10.1056/NEJMra011913. PMID: 12140303.
  3. Skaug HK, Fevang BT, Assmus J, Diamantopoulos AP, Myklebust G, Brekke LK. Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020. Front Med (Lausanne). 2023 Dec 12;10:1296393. doi: 10.3389/fmed.2023.1296393. PMID: 38148911; PMCID: PMC10749960.
  4. Blanco R, Aldasoro V, Maiz O, Melero R, Romero-Yuste S, de Miguel E, Ferraz-Amaro I, López-Gutiérrez F, Castañeda S, Loricera J; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases. Rheumatology (Oxford). 2025 May 1;64(5):2928-2936. doi: 10.1093/rheumatology/keae666. PMID: 39658241.
  5. González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998 Aug;41(8):1497-504. doi: 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z. PMID: 9704651.
  6. Martín-Gutiérrez A, Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Martín JS, Narváez J, Calvo I, Aldasoro V, Abasolo Alcázar L, Loricera J, Ruíz-Roman A, Castañeda S, Molina-Almela C, Alcalde Villar M, Juan Mas A, Blanco R; ARTESER Project Collaborative Group. Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry. Rheumatology (Oxford). 2025 Jun 1;64(6):3733-3738. doi: 10.1093/rheumatology/keaf051. PMID: 39918980.
  7. Martín-Gutiérrez A, Loricera J, Narváez J, Aldasoro V, Maiz O, Vela P, Romero-Yuste S, de Miguel E, Galíndez-Agirregoikoa E, Fernández-López JC, Ferraz-Amaro I, Sánchez-Martín J, Moya P, Campos C, López-Gutiérrez F, Castañeda S, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. Eur J Intern Med. 2024 Nov;129:78-86. doi: 10.1016/j.ejim.2024.06.013. Epub 2024 Jun 22. PMID: 38908981.
  8. Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC, Bonnotte B. Recent advances in our understanding of giant cell arteritis pathogenesis. Autoimmun Rev. 2017 Aug;16(8):833-844. doi: 10.1016/j.autrev.2017.05.014. Epub 2017 May 28. PMID: 28564617.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable